We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Santech Holdings Ltd (STEC) ADR

Sell:$1.01 Buy:$1.07 Change: $0.02 (1.90%)
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Sell:$1.01
Buy:$1.07
Change: $0.02 (1.90%)
Deal now Deal for just £11.95 per trade in a SIPP or Fund and Share Account
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Sell:$1.01
Buy:$1.07
Change: $0.02 (1.90%)
Market closed |  Prices as at close on 21 November 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Santech Holdings Ltd, formerly Hywin Holdings Ltd, is a consumer-focused technology company principally engaged in health management service business. The health management services mainly include providing medical examination, chronic disease management, immune system enhancement, and anti-aging solutions. The Company is also exploring new opportunities in technology, including but not limited to new retail, social e-commerce and metaverse. The Company mainly conducts its business within domestic market.

Contact details

Address:
F3
8 Yincheng Mid. Road, Pudong New Dist.
SHANGHAI
200120
China
Telephone:
+86 (21) 80133888
Website:
https://ir.santechholdings.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
STEC
ISIN:
US44951X1046
Market cap:
$29.40 million
Shares in issue:
56.00 million
Sector:
Asset Management & Custody Banks
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Hongwei Han
    Chairman of the Board
  • Dian Wang
    Chief Executive Officer, Director
  • Wai Lok
    Chief Financial Officer
  • Zheng Liu
    Chief Marketing Officer
  • Gui Wang
    Vice President of Strategy
  • Wen Xiao
    Vice President of Overseas Business
  • Huichuan Zhou
    Vice President of Strategic Projects

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.